Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
Abstract Objectives The survival advantage of radiotherapy (RT) for patients with stage IV non‐small cell lung cancer (NSCLC) has not been adequately evaluated. Methods We analyzed stage IV NSCLC patients enrolled from the Surveillance, Epidemiology, and End Results (SEER) registry through January 2...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2018-10-01
|
| Ráidu: | Cancer Medicine |
| Liŋkkat: | https://doi.org/10.1002/cam4.1776 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|